BioMarin Pharmaceutical Inc. · 6 days ago
Director, US Value, Access and Policy Analytics
San Rafael, CA
Full-time
Hybrid
Director/Executive
$192K/yr - $264K/yr
7+ years expBioMarin Pharmaceutical Inc. is a global biotechnology company focused on translating genetic discoveries into new medicines. The US Value, Access and Policy Analytics Director will develop strategies for patient access and reimbursement, provide analytical support, and collaborate with various stakeholders to enhance the company's market presence.
BiotechnologyDeveloper PlatformPharmaceutical
Responsibilities
Develop tools and materials (e.g. budget impact models) to support product launches and ongoing product commercialization
Support payer engagement activities, including national and regional commercial payers, PBMS, Medicare and Medicaid
Partner with pricing, HEOR, government affairs, patients services and field access teams to develop compelling economic arguments, value propositions and evidence plans
Develop value tools and resources (AMCP dossiers, value decks, coverage policies)
Monitor policy, reimbursement, and pricing landscape and assess implications for the business
Develop predictive models to assess the impact of healthcare policy changes, competitive launches, and evolving payer dynamics
Support contracting strategy development and assist with negotiations as needed
Support good relationships with external vendors, consultants and payer advisors
Analyze access and utilization data to inform strategy and measure performance
Qualification
Required
Minimum 7+ years of progressive experience in US market access, managed markets, payer strategy or related pharmaceutical functions
Proficient analytical skills and use of relevant tools and systems
Deep understanding and experience in pricing dynamics
Deep understanding of U.S. healthcare system, reimbursement mechanisms, and payer landscape
Deep understanding of health policy & health system environment for transformative and rare therapies
Superior problem-solving skills, including demonstrated capability of applying previous experience to complex policy issues
Excellent communication, collaboration, influence, strategic and analytical skills are required
Ability to work optimally in cross-functional teams in a fast-paced, dynamic environment
Advanced analytics skills, scenario modeling, and financial implications assessment of policy issues
Ability to translate complex data into actionable insights for non-technical stakeholders
Strong command of Microsoft Excel to build and maintain complex models
Proficiency in other Microsoft Office Suite applications
Preferred
US launch experience in specialty therapeutics (Oncology, rare disease, immunology)
Experience with Medicare Part B/D, Medicaid and commercial payers
Familiarity with ICER, QALY models, and evidence-based value frameworks
Understanding of value-based contracting and innovative reimbursement models
Bachelors, preferably in life sciences, data sciences or economics/finance
MBA or MPH, preferred
Company
BioMarin Pharmaceutical Inc.
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$585.8M2020-05-11Post Ipo Debt· $585.8M
1999-07-26IPO
Leadership Team
Brian Mueller
Chief Financial Officer
Cristin Hubbard
Chief Commercial Officer
Recent News
Morningstar.com
2026-01-09
Company data provided by crunchbase